Travel trends in Latin America are focusing on wellness, sustainability, and bespoke experiences, with various unique ...

Congressional District faces significant health challenges, with obesity at 40.4%, diabetes at 12.3% and high blood pressure at 37%. Life expectancy is 75.9 years, below the U.S. average of 78.7 years ...

Obesity is more than just a diet and exercise issue; it's deeply intertwined with psychological and social factors. Experts ...

Higher BMI in early adulthood and midlife is linked to better memory performance, particularly in men and Black Americans, ...

U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...

From school meals to food labelling standards, contributors to our mini-series on Cayman's obesity crisis highlight a range ...

After a pandemic and a Chapter 11 restructuring, LATAM Airlines has emerged as a dominant player in South America. Read why ...

LONDON/SAN FRANCISCO, Feb 4 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema amid ...

Doctors and researchers say the injectable drugs are a effective tools when it comes to treating obesity. The American Medical Association has urged health insurance companies to cover the drugs, and ...

TOKYO -- After a year of record profits, Japan's Chugai Pharmaceutical is riding high in the stock market on hopes for an obesity drug under development, but its prospects could be dimmed if Robert F.

More U.S. adults believe it is a good thing than a bad thing for adults to use weight-loss drugs like Ozempic, Wegovy and other brands if they are struggling with obesity or have a health ...